Article
FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer
18 Nov 2023
Abstract excerpt
Nowadays, lung cancer is the most common cause of cancer-related deaths in both men and women globally. Despite the development of extremely efficient targeted agents, lung cancer progression and drug resistance remain serious clinical issues. Increasing knowledge of the molecular mechanisms underlying progression and drug resistance will enable the development of novel therapeutic methods. It has been revealed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
